Response to Mishra et al. re "Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2"
- PMID: 34672802
- DOI: 10.1089/vim.2021.0147
Response to Mishra et al. re "Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2"
Similar articles
-
Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone.JAMA. 2023 Feb 21;329(7):531. doi: 10.1001/jama.2023.0743. JAMA. 2023. PMID: 36723971 No abstract available.
-
Safety and humoral responses to BNT162b2 mRNA vaccination of SARS-CoV-2 previously infected and naive populations.Sci Rep. 2021 Aug 16;11(1):16543. doi: 10.1038/s41598-021-96129-6. Sci Rep. 2021. PMID: 34400714 Free PMC article.
-
Re: "Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2" by Krsak et al.Viral Immunol. 2021 Nov;34(9):658. doi: 10.1089/vim.2021.0131. Epub 2021 Oct 21. Viral Immunol. 2021. PMID: 34672807 No abstract available.
-
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.Nat Rev Immunol. 2021 Jun;21(6):395-404. doi: 10.1038/s41577-021-00550-x. Epub 2021 Apr 29. Nat Rev Immunol. 2021. PMID: 33927374 Free PMC article. Review.
-
SARS-CoV-2 reinfection and implications for vaccine development.Hum Vaccin Immunother. 2020 Dec 1;16(12):3061-3073. doi: 10.1080/21645515.2020.1830683. Hum Vaccin Immunother. 2020. PMID: 33393854 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous